Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
复制标题
DOI:
10.1016/j.apsb.2020.10.005
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Zacconi FC
中科院分区:
文献类型:
--
作者:
Charbe NB;Amnerkar ND;Ramesh B;Tambuwala MM;Bakshi HA;Aljabali AAA;Khadse SC;Satheeshkumar R;Satija S;Metha M;Chellappan DK;Shrivastava G;Gupta G;Negi P;Dua K;Zacconi FC
In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. This review aims to highlight the latest development in the lipids and polymeric nanocarrier for siRNA delivery to the cancer cells. It also provides the necessary information about siRNA development and its mechanism of action. Overall, this review gives us a clear picture of lipid and polymer-based drug delivery systems, which in the future could form the base to translate the basic siRNA biology into siRNA-based cancer therapies. The latest development in the lipids and polymeric nanocarrier for siRNA delivery to the cancer cells were highlighted. It also provides the necessary information about siRNA development and its mechanism of action.
登录
查看更多内容
影响因子:
4
作者:
BENNETT, MJ;NANTZ, MH;MALONE, RW
通讯作者:
MALONE, RW
DOI:
10.3181/0808-mr-250
发表时间:
2009-02
期刊:
Experimental biology and medicine (Maywood, N.J.)
影响因子:
--
作者:
Blanco E;Kessinger CW;Sumer BD;Gao J
通讯作者:
Gao J
影响因子:
2.8
作者:
Arami, S.;Rashidi, M. R.;Entezami, A. A.
通讯作者:
Entezami, A. A.
影响因子:
64.8
作者:
Brummelkamp, TR;Nijman, SMB;Bernards, R
通讯作者:
Bernards, R
影响因子:
14
作者:
Andersen, Morten O.;Lichawska, Agata;Howard, Kenneth A.
通讯作者:
Howard, Kenneth A.